ImClone Investigational Site

Buffalo, New York 14263

0 studies enrolling now · 4 studies all time

What they study most

Colorectal Cancer, Metastatic Malignant Melanoma, Metastatic Renal Cell Carcinoma, Prostate Cancer

Studies at this site

• Study Using IMC-A12 (Cixutumumab) With or Without Cetuximab in Participants With Metastatic Colorectal Cancer Who Have Failed a Treatment Regimen That Consisted of a Prior Anti-EGFR Therapy — Completed
• A Study of IMC-A12 or Ramucirumab Plus Mitoxantrone and Prednisone in Prostate Cancer — Completed
• A Study of IMC-1121B (Ramucirumab) With or Without Dacarbazine in Metastatic Malignant Melanoma — Completed
• A Study of Ramucirumab in Participants With Metastatic Renal Cell Carcinoma — Completed